Author

Alexander J. Dimitri

Abramson Cancer CenterORCID 0000-0002-7337-3196Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Aditi ChandraiD· 1 shared Alexander T. DilsiD· 1 shared Amy E. BaxteriD· 1 shared Bruce L. LevineiD· 1 shared Caitlin R. HopkinsiD· 1 shared Christopher Holliday· 1 shared David L. PorteriD· 1 shared E. John WherryiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aditi ChandraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function

Alexander J. Dimitri, Amy E. Baxter, Gregory M. Chen, Caitlin R. Hopkins, Geoffrey T. Rouin, Hua Huang, Weimin Kong, Christopher Holliday, Volker Wiebking, Robert L. Bartoszek, Sydney Drury, Katherine Dalton, O. M. Koucky, Zeyu Chen, Josephine Ruth Giles, , Joseph A. Fraietta

This study shows that targeting TET2 in CAR T-cells improves their anti-tumor responses by limiting terminal exhaustion and enhancing therapeutic potential.

Science Advances · Nov 13, 2024Peer-reviewedImmunology